Innovate Biopharma (INNT) Appoints Saira Ramasastry to Board; Announces Resignation of Anna Kazanchyan M.D. from Board

Go back to Innovate Biopharma (INNT) Appoints Saira Ramasastry to Board; Announces Resignation of Anna Kazanchyan M.D. from Board

Seaport Global Securities Starts Innovate Biopharma (INNT) at Buy

June 13, 2018 6:08 AM EDT

Seaport Global Securities initiates coverage on Innovate Biopharma (NASDAQ: INNT) with a Buy rating and a price target of $32.00.

For an analyst ratings summary and ratings history on Innovate Biopharma click here. For more ratings news on Innovate Biopharma click here.

Shares of Innovate Biopharma closed at $10.31 yesterday.

... More